Hendley & CO Inc Abbott Laboratories Transaction History

Hendley & CO Inc

$287 Million
Q3 2024

A detailed history of Hendley & CO Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Hendley & CO Inc holds 105,452 shares of ABT stock, worth $12 Million. This represents 4.19% of its overall portfolio holdings.

Number of Shares

105,452

Previous 106,155 0.66%

Holding current value

$12 Million

Previous $11 Million 8.99%

% of portfolio

4.19%

Previous 3.96%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$100.07 - $118.13 $70,349 - $83,045	-703 Reduced 0.66%	105,452 $12 Million
Q2 2024 Jul 16, 2024	SELL	$100.73 - $112.44 $324,350 - $362,056	-3,220 Reduced 2.94%	106,155 $11 Million
Q1 2024 May 02, 2024	SELL	$109.52 - $120.96 $48,626 - $53,706	-444 Reduced 0.4%	109,375 $12.4 Million
Q4 2023 Jan 26, 2024	SELL	$90.19 - $110.4 $206,986 - $253,368	-2,295 Reduced 2.05%	109,819 $12.1 Million
Q3 2023 Oct 25, 2023	BUY	$95.53 - $114.62 $316,968 - $380,309	3,318 Added 3.05%	112,114 $10.9 Million
Q2 2023 Aug 11, 2023	BUY	$100.78 - $112.29 $6,248 - $6,961	62 Added 0.06%	108,796 $11.9 Million
Q1 2023 Apr 24, 2023	SELL	$96.86 - $114.01 $35,838 - $42,183	-370 Reduced 0.34%	108,734 $11 Million
Q4 2022 Jan 24, 2023	BUY	$95.06 - $111.52 $9,506 - $11,152	100 Added 0.09%	109,104 $12 Million
Q3 2022 Oct 20, 2022	SELL	$96.76 - $112.03 $290 - $336	-3 Reduced -0.0%	109,004 $10.5 Million
Q2 2022 Jul 28, 2022	BUY	$102.07 - $123.37 $65,835 - $79,573	645 Added 0.6%	109,007 $11.8 Million
Q1 2022 Apr 29, 2022	SELL	$114.02 - $139.04 $19,725 - $24,053	-173 Reduced 0.16%	108,362 $12.8 Million
Q4 2021 Feb 02, 2022	SELL	$115.53 - $141.46 $30,268 - $37,062	-262 Reduced 0.24%	108,535 $15.3 Million
Q3 2021 Oct 27, 2021	SELL	$116.66 - $129.06 $20,998 - $23,230	-180 Reduced 0.17%	108,797 $12.9 Million
Q2 2021 Jul 30, 2021	BUY	$105.79 - $124.53 $140,806 - $165,749	1,331 Added 1.24%	108,977 $12.6 Million
Q1 2021 Apr 22, 2021	SELL	$108.84 - $128.23 $129,519 - $152,593	-1,190 Reduced 1.09%	107,646 $12.9 Million
Q4 2020 Jan 19, 2021	BUY	$105.0 - $114.42 $2.82 Million - $3.07 Million	26,842 Added 32.74%	108,836 $11.9 Million
Q3 2020 Oct 21, 2020	SELL	$91.64 - $111.29 $231,207 - $280,784	-2,523 Reduced 2.99%	81,994 $8.92 Million
Q2 2020 Aug 12, 2020	BUY	$76.57 - $98.0 $765 - $980	10 Added 0.01%	84,517 $7.73 Million
Q1 2020 May 05, 2020	BUY	$62.82 - $91.86 $123,127 - $180,045	1,960 Added 2.37%	84,507 $6.67 Million
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $321,812 - $358,252	4,099 Added 5.23%	82,547 $7.17 Million
Q3 2019 Oct 15, 2019	BUY	$81.84 - $88.74 $2.82 Million - $3.06 Million	34,429 Added 78.21%	78,448 $6.56 Million
Q2 2019 Aug 08, 2019	BUY	$72.88 - $85.0 $140,658 - $164,050	1,930 Added 4.59%	44,019 $3.7 Million
Q1 2019 May 20, 2019	SELL	$66.22 - $80.06 $45,559 - $55,081	-688 Reduced 1.61%	42,089 $3.37 Million
Q4 2018 Jan 22, 2019	SELL	$65.56 - $74.27 $41,958 - $47,532	-640 Reduced 1.47%	42,777 $3.09 Million
Q3 2018 Oct 29, 2018	SELL	$60.81 - $73.36 $43,722 - $52,745	-719 Reduced 1.63%	43,417 $3.19 Million
Q2 2018 Jul 27, 2018	SELL	$57.57 - $63.54 $250,141 - $276,081	-4,345 Reduced 8.96%	44,136 $2.69 Million
Q1 2018 May 08, 2018	SELL	$56.27 - $63.62 $28,979 - $32,764	-515 Reduced 1.05%	48,481 $2.91 Million
Q4 2017 Feb 01, 2018	SELL	$53.68 - $57.47 $93,886 - $100,515	-1,749 Reduced 3.45%	48,996 $2.8 Million
Q3 2017 Oct 23, 2017	BUY	$48.06 - $53.64 $2.44 Million - $2.72 Million	50,745	50,745 $2.71 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hendley & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hendley & CO Inc with notifications on news.

Account